VERV Gains 25.03%

Mon, Jun 28, 2021 at 05:30 PM

VERV (VERV:NASDAQ) shot up at $45, representing a gain of 25%. The stock got featured on our News Catalysts scanner on Thu, Jun 24, 2021 at 08:49 AM in the 'PUBLIC OFFERING' category. From Thu, Jun 17, 2021, the stock recorded 33.33% Up Days and 42.86% Green Days

The share price of the company has been moving sideways in recent weeks.

About VERV (VERV:NASDAQ)

Verve Therapeutics Inc is a genetic medicines company pioneering the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines.

Top 10 Gainers:

Marin Software Incorporated (MRIN:NASDAQ), 96.85%
QAD Inc. (QADB:NASDAQ), 79.79%
Intellia Therapeutics, Inc. (NTLA:NASDAQ), 50.21%
AUUD (AUUD:NASDAQ), 43.66%
Wireless Telecom Group, Inc. (WTT:NYSEMKT), 30.89%
New Senior Investment Group Inc. (SNR:NYSE), 29.09%
ISPC (ISPC:NASDAQ), 25.66%
VERV (VERV:NASDAQ), 25.03%
JinkoSolar Holding Co., Ltd. (JKS:NYSE), 22.91%
ENVB (ENVB:NASDAQ), 19.82%